Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Semaglutide 2.4 mg (Wegovy) and tirzepatide (Zepbound) are approved for adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
The strongest predictors are baseline IGF-1 level, age, sleep quality (7-9 hours nightly), training consistency (4-6 days/week), diet quality, and protocol adherence
When you support Tirzepatide with a well-balanced meal guide , your body adapts better, and your side effects (like nausea or fatigue) stay minimal
This allows sufficient volume per muscle group (10-16 hard sets per week) and provides enough recovery time between sessions
US$ 20.64
US$ 23.77
US$ 20.00
